Article Text

Download PDFPDF
Review
Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers
  1. Edwin Jabbari1,
  2. Henrik Zetterberg1,2,
  3. Huw R Morris1
  1. 1 Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK
  2. 2 Institute of Neuroscience and Physiology, Goteborgs Universitet, Gothenburg, Sweden
  1. Correspondence to Prof Huw R Morris, Department of Clinical Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; h.morris{at}ucl.ac.uk

Footnotes

  • Contributors EJ performed the literature review and wrote this manuscript.

    HZ and HRM individually reviewed and edited the manuscript.

  • Funding EJ has been supported by the PSP Association. HZ has been supported by the Swedish and European Research Councils and the Wolfson Foundation. HRM has been supported by the PSP Association, Drake Foundation, Parkinson’s UK and the Medical Research Council.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors EJ performed the literature review and wrote this manuscript.

    HZ and HRM individually reviewed and edited the manuscript.

  • Funding EJ has been supported by the PSP Association. HZ has been supported by the Swedish and European Research Councils and the Wolfson Foundation. HRM has been supported by the PSP Association, Drake Foundation, Parkinson’s UK and the Medical Research Council.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.